e.l.f. Cosmetics
ELF
$114.24
-0.65%
e.l.f. Beauty, Inc. is a multi-brand mass-market beauty company that designs and sells color cosmetics, skin care, and personal care products — including eyeliner, mascara, foundation, lipstick, cleansers, and moisturizers — under the e.l.f. Cosmetics, e.l.f. Skin, and acquired Rhode brands, distributed primarily through mass retailers, drugstores, and e-commerce channels in the Consumer Defensive household and personal products space. The company has built its identity as a value-price disruptor that pairs a fast, low-cost supply chain with viral, digitally native marketing, positioning it as a share-gainer against legacy prestige and mass beauty incumbents rather than a premium niche player. The current investor narrative is dominated by the Rhode acquisition and its role in re-accelerating growth — Q1 FY2027 revenue rose roughly 35.5% year over year with a raised outlook, and headlines such as "Rhode Is Fueling e.l.f.'s Latest Surge" and a 32% June rally tied to a new hair care line and tariff refunds have refocused debate on whether the growth is durable. That bullish momentum is set against a sharp prior drawdown, a reported 33% profit-margin decline flagged earlier in the year, and a still-elevated absolute valuation, leaving investors to weigh a genuine multi-brand growth platform against acquisition-dependent growth and margin volatility.…
ELF
e.l.f. Cosmetics
$114.24
Related headlines
Investment Opinion: Should I buy ELF Today?
The synthesized recommendation is Hold. While the company demonstrates strong revenue growth (35.5% YoY) and margin expansion (gross margin 83.2%), the current valuation appears stretched, with the average analyst target of $108.88 slightly below the current price of $113.54, offering limited upside. The consensus rating is Buy, but the risk/reward is balanced given the high trailing P/E of 134.7x and thin net margin of 1.6%. Supporting evidence includes the impressive top-line momentum, with revenue reaching $479.4M in Q1 FY2027, and a forward P/E of 29.1x that is more reasonable but still above the sector average. Free cash flow of $280.2M TTM is a positive, and the gross margin trend is improving. However, the net margin is only 1.6%, and the company experienced a net loss in Q4 FY2026, highlighting earnings instability. The stock's beta of 1.60 and max drawdown of -66.2% indicate high volatility. Key risks include acquisition integration, potential slowdown in Rhode growth, and valuation compression. The rating would upgrade to Buy if the forward P/E drops below 25x or if organic growth (excluding acquisitions) accelerates above 20%. It would downgrade to Sell if revenue growth decelerates below 15% or if net margin fails to improve. Relative to its history, the stock is fairly valued to slightly overvalued, given the premium multiples.
Sign up to view all
ELF 12-Month Price Forecast
The forward-looking view is balanced. ELF's strong revenue growth and margin expansion are compelling, but the valuation already reflects much of the optimism, with the average analyst target below the current price. The stock's high volatility and acquisition-dependent growth add risk. We would upgrade to bullish if the company demonstrates sustained organic growth above 20% and net margin expansion, or if the stock pulls back to a more attractive valuation (e.g., forward P/E below 25x). We would downgrade to bearish if revenue growth decelerates below 15% or if margin pressures intensify.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on e.l.f. Cosmetics's 12-month outlook, with a consensus price target around $114.94 and implied upside of +0.6% versus the current price.
Average Target
$114.94
0 analysts
Implied Upside
+0.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $137
Analyst target range
Bulls vs Bears: ELF Investment Factors
The bull case for ELF rests on impressive revenue re-acceleration (35.5% YoY), margin expansion (gross margin 83.2%), and strong free cash flow, supported by a Buy consensus and positive momentum. However, the bear case highlights extreme trailing valuation (P/E 134.7x), thin net margins (1.6%), and acquisition-dependent growth, with the average analyst target below the current price. Currently, the bear evidence appears slightly stronger due to valuation concerns and margin volatility, but the bull momentum is powerful. The single most important tension is whether the Rhode-driven growth is durable and can be sustained organically after integration, which will determine if the premium valuation is justified.
Bullish
- Revenue re-acceleration to 35.5% YoY: Q1 FY2027 revenue reached $479.4M, up 35.5% year over year, driven by the Rhode acquisition and organic momentum. This is a sharp acceleration from the prior year's Q1 growth of roughly 18% (from $353.7M to $479.4M), demonstrating that the multi-brand strategy is translating into top-line gains.
- Gross margin expansion to 83.2%: Q1 FY2027 gross margin hit 83.2%, up from 69.1% in Q1 FY2026 and 72.7% in Q4 FY2026. This 14.1 percentage point year-over-year improvement suggests pricing power and a favorable product mix, including higher-margin Rhode products, which could drive operating leverage.
- Strong free cash flow of $280M TTM: Despite a reported profit-margin decline earlier in the year, trailing twelve-month free cash flow stands at $280.2M, representing about 15% of TTM revenue. This cash generation supports debt servicing (debt-to-equity of 0.81) and potential reinvestment in growth initiatives.
- Analyst consensus Buy with 16 analysts: The stock carries a consensus recommendation of 'Buy' (mean rating 1.72 on a 1-5 scale) from 16 analysts, with an average target price of $108.88. Although the current price of $113.54 is slightly above the average target, the high target of $130 implies a 14.5% upside, reflecting continued optimism.
Bearish
- Extreme trailing valuation: The trailing P/E ratio is 134.7x, and the EV/EBITDA is 25.9x, both indicating a very rich valuation relative to the broader market and sector. Even the forward P/E of 29.1x, while more reasonable, prices in significant growth that may be difficult to sustain.
- Profit margin volatility and net margin compression: The net margin is only 1.6%, and the company reported a 33% profit-margin decline earlier in the year. Q4 FY2026 showed a net loss of $49.4M (EPS -$0.84), highlighting earnings instability despite revenue growth.
- Acquisition-dependent growth: The recent revenue surge is heavily attributed to the Rhode acquisition, as noted in news headlines. Organic growth excluding Rhode may be lower, and the company faces integration risks and potential slowdown as acquisition contributions annualize.
- High beta and volatility: With a beta of 1.60, ELF is significantly more volatile than the market. The stock has a max drawdown of -66.2% and a 52-week range from $48.82 to $139.35, indicating sharp price swings that could expose investors to substantial losses.
ELF Technical Analysis
Beta
1.60
1.60x market volatility
Max Drawdown
-66.2%
Largest decline past year
52-Week Range
$49-$132
Price range past year
Annual Return
-8.6%
Cumulative gain past year
| Period | ELF Return | S&P 500 |
|---|---|---|
| 1m | +13.4% | -1.0% |
| 3m | +47.7% | +2.9% |
| 6m | +72.4% | +6.5% |
| 1y | -8.6% | +13.1% |
| ytd | +46.8% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ELF Fundamental Analysis
Quarterly Revenue
$479373000.0B
2026-06
Revenue YoY Growth
+35.5%
YoY Comparison
Gross Margin
83.2%
Latest Quarter
Free Cash Flow
$280157999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ELF Overvalued?
PE
134.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 16x~101x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company carries a debt-to-equity ratio of 0.81, and interest expense was $7.8M in Q1 FY2027, up from $2.6M in Q1 FY2026, indicating rising leverage. Net margin is razor-thin at 1.6%, and Q4 FY2026 swung to a net loss of $49.4M, showing earnings volatility. Additionally, revenue concentration in the Rhode brand and mass retail channels poses a risk if consumer preferences shift or if retailer relationships deteriorate. The current ratio of 2.35 provides some liquidity cushion, but the high operating margin of 8.0% leaves little room for error. Market and competitive risks include valuation compression: the trailing P/E of 134.7x and EV/EBITDA of 25.9x are well above typical consumer staples multiples, and any growth disappointment could trigger a sharp de-rating. The beta of 1.60 means the stock is highly sensitive to market swings, and sector rotation away from growth stocks (as seen in recent news about rotation from rate-sensitive growth) could pressure shares. Competition from legacy beauty brands and other value players could erode market share, and tariff refunds that boosted June performance may not recur. The worst-case scenario involves a combination of slowing Rhode sales, margin compression, and a market rotation away from high-multiple stocks. Given the 52-week low of $48.82, a decline to that level from the current $113.54 would represent a 57% loss. The analyst low target of $65 implies a 42.8% downside. With a max drawdown of -66.2% historically, investors could face severe losses if growth stalls and valuation normalizes.
FAQ
The key risks include: 1) Valuation risk: high multiples could compress if growth slows, as seen with the max drawdown of -66.2%. 2) Earnings volatility: net margin is only 1.6%, and the company reported a net loss in Q4 FY2026. 3) Acquisition integration risk: growth is heavily dependent on Rhode, and any slowdown could hurt. 4) Macro sensitivity: beta of 1.60 means the stock is volatile and sensitive to market rotations, especially away from growth stocks. These risks are ranked from high to moderate, with valuation and earnings volatility being most severe.
Our 12-month forecast has a base case (50% probability) of $105-115, aligned with the analyst average target of $108.88, assuming revenue growth moderates to 20-25%. The bull case (25% probability) targets $130-140, driven by sustained high growth and multiple expansion. The bear case (25% probability) targets $65-80, reflecting a growth slowdown and valuation compression. The most likely scenario is the base case, with the key assumption that Rhode continues to contribute and margins stabilize.
ELF appears overvalued on trailing metrics, with a P/E of 134.7x and EV/EBITDA of 25.9x, well above typical consumer staples multiples. However, the forward P/E of 29.1x suggests the market expects strong earnings growth. The PEG ratio is negative due to recent losses, making it less useful. Compared to its own history, the stock has traded at high multiples, but the current price is near the analyst average target, implying fair value to slightly overvalued. The market is pricing in continued rapid growth, leaving little room for disappointment.
ELF presents a high-risk, high-reward opportunity. The stock has strong momentum, up 54% in three months, and revenue growth of 35.5% YoY, but the valuation is stretched with a trailing P/E of 134.7x and a forward P/E of 29.1x. The average analyst target of $108.88 is below the current price, suggesting limited upside, while the low target of $65 implies significant downside. For risk-tolerant investors with a long-term view, ELF could be a good buy on pullbacks, but current levels may not offer an attractive entry point.
ELF is more suitable for long-term investors with a high risk tolerance, given its growth stage and volatility. The stock has a beta of 1.60 and no dividend, so it does not provide income. Earnings visibility is moderate, with analyst estimates for EPS of $5.80 in the next fiscal year. Short-term trading could be profitable given the momentum, but the high volatility (max drawdown -66.2%) makes it risky. A minimum holding period of 2-3 years is recommended to ride out fluctuations and allow the growth story to unfold.